# Studies With 1,25-Dihydroxycholecalciferol

> **NCT00001151** · PHASE2 · TERMINATED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 6 (actual)

## Conditions studied

- Hypocalcemia
- Rickets

## Interventions

- **DRUG:** 1,25-Dihydroxycholecalciferol

## Key facts

- **NCT ID:** NCT00001151
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1976-03
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Terminated because of lack of drug supply
- **Last updated:** 2013-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001151, "Studies With 1,25-Dihydroxycholecalciferol". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00001151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*